The variation trend of tumour volume was consistent with that of tumour weight, as indicated in Fig. 5g–i, wherein HMME/R837@Lip-augmented SDT combined with anti-PD-L1 blockade acquired the largest reduction of tumour weight, in both primary and distant tumours. This evidence concerns the gene CD274 and neoplasm.